HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,267,109 | +4.5% | 14,145 | -0.7% | 0.23% | +9.5% |
| Q2 2023 | $1,212,564 | +2.3% | 14,242 | -0.6% | 0.21% | +1.0% |
| Q1 2023 | $1,185,559 | +6.8% | 14,327 | +1.5% | 0.21% | +8.9% |
| Q4 2022 | $1,110,223 | +6.8% | 14,116 | +0.5% | 0.19% | -2.0% |
| Q3 2022 | $1,040,000 | -6.0% | 14,051 | -17.2% | 0.20% | +2.1% |
| Q2 2022 | $1,106,000 | -6.7% | 16,965 | -4.7% | 0.19% | +46.6% |
| Q2 2021 | $1,186,000 | +33.0% | 17,804 | +78.7% | 0.13% | -9.0% |
| Q2 2020 | $892,000 | +26.5% | 9,964 | -36.6% | 0.14% | +45.5% |
| Q3 2017 | $705,000 | +60.2% | 15,715 | +15.4% | 0.10% | +13.8% |
| Q3 2015 | $440,000 | – | 13,615 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |